Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Pliant Therapeutics (PLRX) Receivables - Net (2019 - 2023)

Pliant Therapeutics (PLRX) has disclosed Receivables - Net for 5 consecutive years, with $1.6 million as the latest value for Q2 2023.

  • Quarterly Receivables - Net fell 68.33% to $1.6 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jun 2023, down 68.33% year-over-year, with the annual reading at $2.0 million for FY2022, 0.75% down from the prior year.
  • Receivables - Net for Q2 2023 was $1.6 million at Pliant Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Receivables - Net was $9.3 million in Q4 2020, with the low at $1.2 million in Q1 2022.
  • Average Receivables - Net over 5 years is $3.5 million, with a median of $2.1 million recorded in 2021.
  • The sharpest move saw Receivables - Net plummeted 78.47% in 2021, then soared 172.62% in 2022.
  • Over 5 years, Receivables - Net stood at $7.1 million in 2019, then soared by 31.58% to $9.3 million in 2020, then tumbled by 78.47% to $2.0 million in 2021, then dropped by 0.75% to $2.0 million in 2022, then fell by 20.32% to $1.6 million in 2023.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $1.6 million, $3.3 million, and $2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.